Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

By W. Kruis, P. Frič, J. Pokrotnieks, M. Lukáš, B. Fixa, M. Kaščák, M. Kamm, J. Weismueller, C. Beglinger, M. Stolte and 2 more. Gut, 2004

1,207 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial (2019, methodology): “Protocol 29th May 2013 27 Two enemas of 100ml faecal suspension will be delivered by a medical practitioner at the clinic in the week following colonoscopy Days (2-4) Days (5-7).”
Probiotic Lactic Acid Bacteria: A Review (2014, background): “Some species conferred beneficial effects, such as the treatment of acute diarrhoea associated with rotavirus [51], ulcerative colitis [65] [66], Clostridium difficile-associated diarrhoea [67], and Helicobacter pylori infection [68] [69].”
Intestinal permeability – a new target for disease prevention and therapy (2014, background): “coli Nissle 1917 supporting maintenance of remission in patients with UC [183,184].”
The gut microbiota and host health: a new clinical frontier (2015, background): “72 Both treatments were deemed equivalent with regards to relapse.”
The first 1000 cultured species of the human gastrointestinal microbiota (2014, background): “The different strains of E. coli can exhibit different properties, varying from probiotic (Kruis et al., 2004) to pathogenic causing diarrhea or infections on other sites (Ron, 2006).”